7-43791289-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The NM_000712.4(BLVRA):āc.175T>Cā(p.Leu59=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.118 in 1,613,934 control chromosomes in the GnomAD database, including 12,140 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.12 ( 1135 hom., cov: 32)
Exomes š: 0.12 ( 11005 hom. )
Consequence
BLVRA
NM_000712.4 synonymous
NM_000712.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.148
Genes affected
BLVRA (HGNC:1062): (biliverdin reductase A) The protein encoded by this gene belongs to the biliverdin reductase family, members of which catalyze the conversion of biliverdin to bilirubin in the presence of NADPH or NADH. Mutations in this gene are associated with hyperbiliverdinemia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 7-43791289-T-C is Benign according to our data. Variant chr7-43791289-T-C is described in ClinVar as [Benign]. Clinvar id is 2118007.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.148 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.189 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BLVRA | NM_000712.4 | c.175T>C | p.Leu59= | synonymous_variant | 4/8 | ENST00000265523.9 | NP_000703.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BLVRA | ENST00000265523.9 | c.175T>C | p.Leu59= | synonymous_variant | 4/8 | 1 | NM_000712.4 | ENSP00000265523 | P1 | |
BLVRA | ENST00000402924.5 | c.175T>C | p.Leu59= | synonymous_variant | 5/9 | 2 | ENSP00000385757 | P1 | ||
BLVRA | ENST00000424330.1 | c.175T>C | p.Leu59= | synonymous_variant | 4/5 | 3 | ENSP00000412005 | |||
BLVRA | ENST00000453612.1 | n.199T>C | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.119 AC: 18114AN: 152022Hom.: 1130 Cov.: 32
GnomAD3 genomes
AF:
AC:
18114
AN:
152022
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.127 AC: 31906AN: 251290Hom.: 2433 AF XY: 0.120 AC XY: 16245AN XY: 135794
GnomAD3 exomes
AF:
AC:
31906
AN:
251290
Hom.:
AF XY:
AC XY:
16245
AN XY:
135794
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.118 AC: 172489AN: 1461794Hom.: 11005 Cov.: 32 AF XY: 0.115 AC XY: 83874AN XY: 727202
GnomAD4 exome
AF:
AC:
172489
AN:
1461794
Hom.:
Cov.:
32
AF XY:
AC XY:
83874
AN XY:
727202
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.119 AC: 18153AN: 152140Hom.: 1135 Cov.: 32 AF XY: 0.122 AC XY: 9047AN XY: 74392
GnomAD4 genome
AF:
AC:
18153
AN:
152140
Hom.:
Cov.:
32
AF XY:
AC XY:
9047
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
393
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
BLVRA-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 22, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at